Peripheral Stent Implant Market Size, Share, Trends, Growth Outlook

Global Peripheral Stent Implant Market size of $1.9 Billion in 2024 and is forecast to register a growth rate (CAGR) of 7.4% to reach $3 Billion by 2030.

The global Peripheral Stent Implant Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Product (Bare Metal Stents, Covered Stents, Drug-Eluting Stents), By Artery (Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents, Infrapop Artery Stents), By End-User (Hospitals, Ambulatory Surgical Centers).

An Introduction to Peripheral Stent Implant Market

Peripheral artery disease (PAD) affects millions worldwide, necessitating interventions like stent placement to restore blood flow in diseased arteries. The Peripheral Stent Implant market is witnessing growth as healthcare providers adopt minimally invasive techniques and advanced stent designs to improve procedural outcomes and patient quality of life. Innovations in drug-eluting and bioresorbable stents further drive market expansion, addressing the evolving needs of patients with peripheral vascular conditions.

Peripheral Stent Implant MarketCompetitive Landscape

The market report analyses the leading companies in the industry including Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corp, Cardinal Health Inc, Cook Medical Inc, iVascular SLU, Medtronic Plc., Microport Scientific Corp, Terumo Corp, Terumo Medical, W. L. Gore & Associates Inc, and others.

Peripheral Stent Implant MarketDynamics

Peripheral Stent Implant Market Trend: Shift Towards Minimally Invasive Peripheral Artery Disease (PAD) Treatments

The Peripheral Stent Implant market is experiencing a prominent trend towards the shift from traditional open surgeries to minimally invasive procedures for treating Peripheral Artery Disease (PAD). Advances in stent technology, such as drug-eluting stents and bioresorbable scaffolds, allow for precise placement and effective treatment of narrowed or blocked peripheral arteries. This trend is driven by the benefits of minimally invasive approaches, including reduced recovery times, lower risk of complications, and improved patient outcomes, leading to increased adoption of peripheral stent implants.

Peripheral Stent Implant Market Driver: Growing Prevalence of Peripheral Artery Disease (PAD) and Cardiovascular Conditions

A key driver for the Peripheral Stent Implant market is the growing prevalence of Peripheral Artery Disease (PAD) and related cardiovascular conditions. Factors such as aging populations, lifestyle-related risk factors (e.g., smoking, diabetes, hypertension), and an increase in sedentary lifestyles contribute to the rise in PAD cases. The need for effective interventions to manage PAD symptoms, prevent limb amputations, and improve patients' quality of life is fueling the demand for peripheral stent implants as a vital treatment option.

Peripheral Stent Implant Market Opportunity: Expansion into Emerging Markets and Innovative Stent Designs

The Market Opportunity for the Peripheral Stent Implant market includes expansion into emerging markets and the development of innovative stent designs. Emerging economies with improving healthcare infrastructures and rising awareness of cardiovascular diseases present untapped markets for peripheral stent implants. Additionally, the advancement of stent technologies, such as bioresorbable stents, drug-coated stents with improved biocompatibility, and stents designed for specific anatomical challenges, offers opportunities for market growth and differentiation. Companies that invest in expanding their market presence and innovating new stent designs can capitalize on these opportunities and meet the evolving needs of healthcare providers and patients.

Market Share Analysis: Peripheral Stent Implant Market Soars, Propelled by Rapid Growth in Drug-Eluting Stents Segment

Within the Peripheral Stent Implant market, the Drug-Eluting Stents segment is experiencing the fastest growth. This surge is primarily driven by several factors. Firstly, drug-eluting stents (DES) offer superior long-term patency rates compared to bare metal stents, reducing the risk of restenosis and the need for repeat interventions in peripheral artery disease (PAD) patients. The incorporation of antiproliferative drugs in DES inhibits neointimal hyperplasia, thereby promoting better outcomes and durability of arterial patency. Additionally, advancements in stent design and drug-eluting technology have led to the development of next-generation DES with improved biocompatibility, flexibility, and drug-release kinetics, further enhancing their clinical efficacy and safety profile. Moreover, the rising prevalence of PAD and the growing demand for minimally invasive treatment options are driving the adoption of drug-eluting stents in peripheral artery interventions. As healthcare providers prioritize the use of innovative technologies to improve patient outcomes and reduce the need for repeat procedures, the Drug-Eluting Stents segment is poised for sustained growth, driving significant momentum in the Peripheral Stent Implant market.

Peripheral Stent Implant Market Report Segmentation

By Product
Bare Metal Stents
Covered Stents
Drug-Eluting Stents
By Artery
Carotid Artery Stents
Fem-Pop Artery Stents
Iliac Artery Stents
Infrapop Artery Stents
By End-User
Hospitals
Ambulatory Surgical Centers
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Peripheral Stent Implant Market Companies Profiled in the Study

Abbott Laboratories
B. Braun Melsungen AG
Biotronik SE & Co. KG
Boston Scientific Corp
Cardinal Health Inc
Cook Medical Inc
iVascular SLU
Medtronic Plc.
Microport Scientific Corp
Terumo Corp
Terumo Medical
W. L. Gore & Associates Inc
*- List Not Exhaustive

 

TABLE OF CONTENTS

1 Introduction to 2024 Peripheral Stent Implant Market Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Peripheral Stent Implant Market Market Size Outlook, $ Million, 2021 to 2030
3.2 Peripheral Stent Implant Market Market Outlook by Type, $ Million, 2021 to 2030
3.3 Peripheral Stent Implant Market Market Outlook by Product, $ Million, 2021 to 2030
3.4 Peripheral Stent Implant Market Market Outlook by Application, $ Million, 2021 to 2030
3.5 Peripheral Stent Implant Market Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Peripheral Stent Implant Market Industry
4.2 Key Market Trends in Peripheral Stent Implant Market Industry
4.3 Potential Opportunities in Peripheral Stent Implant Market Industry
4.4 Key Challenges in Peripheral Stent Implant Market Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Peripheral Stent Implant Market Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Peripheral Stent Implant Market Market Outlook by Segments
7.1 Peripheral Stent Implant Market Market Outlook by Segments, $ Million, 2021- 2030
By Product
Bare Metal Stents
Covered Stents
Drug-Eluting Stents
By Artery
Carotid Artery Stents
Fem-Pop Artery Stents
Iliac Artery Stents
Infrapop Artery Stents
By End-User
Hospitals
Ambulatory Surgical Centers

8 North America Peripheral Stent Implant Market Market Analysis and Outlook To 2030
8.1 Introduction to North America Peripheral Stent Implant Market Markets in 2024
8.2 North America Peripheral Stent Implant Market Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Peripheral Stent Implant Market Market size Outlook by Segments, 2021-2030
By Product
Bare Metal Stents
Covered Stents
Drug-Eluting Stents
By Artery
Carotid Artery Stents
Fem-Pop Artery Stents
Iliac Artery Stents
Infrapop Artery Stents
By End-User
Hospitals
Ambulatory Surgical Centers

9 Europe Peripheral Stent Implant Market Market Analysis and Outlook To 2030
9.1 Introduction to Europe Peripheral Stent Implant Market Markets in 2024
9.2 Europe Peripheral Stent Implant Market Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Peripheral Stent Implant Market Market Size Outlook by Segments, 2021-2030
By Product
Bare Metal Stents
Covered Stents
Drug-Eluting Stents
By Artery
Carotid Artery Stents
Fem-Pop Artery Stents
Iliac Artery Stents
Infrapop Artery Stents
By End-User
Hospitals
Ambulatory Surgical Centers

10 Asia Pacific Peripheral Stent Implant Market Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Peripheral Stent Implant Market Markets in 2024
10.2 Asia Pacific Peripheral Stent Implant Market Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Peripheral Stent Implant Market Market size Outlook by Segments, 2021-2030
By Product
Bare Metal Stents
Covered Stents
Drug-Eluting Stents
By Artery
Carotid Artery Stents
Fem-Pop Artery Stents
Iliac Artery Stents
Infrapop Artery Stents
By End-User
Hospitals
Ambulatory Surgical Centers

11 South America Peripheral Stent Implant Market Market Analysis and Outlook To 2030
11.1 Introduction to South America Peripheral Stent Implant Market Markets in 2024
11.2 South America Peripheral Stent Implant Market Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Peripheral Stent Implant Market Market size Outlook by Segments, 2021-2030
By Product
Bare Metal Stents
Covered Stents
Drug-Eluting Stents
By Artery
Carotid Artery Stents
Fem-Pop Artery Stents
Iliac Artery Stents
Infrapop Artery Stents
By End-User
Hospitals
Ambulatory Surgical Centers

12 Middle East and Africa Peripheral Stent Implant Market Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Peripheral Stent Implant Market Markets in 2024
12.2 Middle East and Africa Peripheral Stent Implant Market Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Peripheral Stent Implant Market Market size Outlook by Segments, 2021-2030
By Product
Bare Metal Stents
Covered Stents
Drug-Eluting Stents
By Artery
Carotid Artery Stents
Fem-Pop Artery Stents
Iliac Artery Stents
Infrapop Artery Stents
By End-User
Hospitals
Ambulatory Surgical Centers

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
Abbott Laboratories
B. Braun Melsungen AG
Biotronik SE & Co. KG
Boston Scientific Corp
Cardinal Health Inc
Cook Medical Inc
iVascular SLU
Medtronic Plc.
Microport Scientific Corp
Terumo Corp
Terumo Medical
W. L. Gore & Associates Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Bare Metal Stents
Covered Stents
Drug-Eluting Stents
By Artery
Carotid Artery Stents
Fem-Pop Artery Stents
Iliac Artery Stents
Infrapop Artery Stents
By End-User
Hospitals
Ambulatory Surgical Centers
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)